119 related articles for article (PubMed ID: 23142110)
1. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.
Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G
Peptides; 2013 Jan; 39():16-20. PubMed ID: 23142110
[TBL] [Abstract][Full Text] [Related]
2. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
[TBL] [Abstract][Full Text] [Related]
3. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
[TBL] [Abstract][Full Text] [Related]
5. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.
Trombella S; Vergura R; Falzarano S; Guerrini R; Calo G; Spisani S
Peptides; 2005 Aug; 26(8):1497-502. PubMed ID: 15922491
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
[TBL] [Abstract][Full Text] [Related]
9. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
Doherty DE; Haslett C; Tonnesen MG; Henson PM
J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of neuropeptide S (NPS) receptor in eosinophils from severe asthmatics and subjects with total IgE above 100IU/ml.
Ilmarinen P; James A; Moilanen E; Pulkkinen V; Daham K; Saarelainen S; Laitinen T; Dahlén SE; Kere J; Dahlén B; Kankaanranta H
Peptides; 2014 Jan; 51():100-9. PubMed ID: 24239856
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
Camarda V; Trapella C; Calo G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2008 Feb; 51(3):655-8. PubMed ID: 18181564
[TBL] [Abstract][Full Text] [Related]
13. Monocyte migration: a novel effect and signaling pathways of catestatin.
Egger M; Beer AG; Theurl M; Schgoer W; Hotter B; Tatarczyk T; Vasiljevic D; Frauscher S; Marksteiner J; Patsch JR; Schratzberger P; Djanani AM; Mahata SK; Kirchmair R
Eur J Pharmacol; 2008 Nov; 598(1-3):104-11. PubMed ID: 18834877
[TBL] [Abstract][Full Text] [Related]
14. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
16. Suppression of polymorphonuclear leucocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: a study of the mechanisms and the correlation with ring abscess in pseudomonal keratitis.
Ijiri Y; Matsumoto K; Kamata R; Nishino N; Okamura R; Kambara T; Yamamoto T
Int J Exp Pathol; 1994 Dec; 75(6):441-51. PubMed ID: 7734333
[TBL] [Abstract][Full Text] [Related]
17. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
18. Time dependence of transmembrane potential changes and intracellular calcium flux in stimulated human monocytes.
Bernardo J; Brink HF; Simons ER
J Cell Physiol; 1988 Jan; 134(1):131-6. PubMed ID: 2826501
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.
Girasole G; Wang JM; Pedrazzoni M; Pioli G; Balotta C; Passeri M; Lazzarin A; Ridolfo A; Mantovani A
J Immunol; 1990 Oct; 145(8):2459-64. PubMed ID: 2212648
[TBL] [Abstract][Full Text] [Related]
20. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
